gliclazide has been researched along with glipizide in 41 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (12.20) | 18.7374 |
| 1990's | 13 (31.71) | 18.2507 |
| 2000's | 8 (19.51) | 29.6817 |
| 2010's | 13 (31.71) | 24.3611 |
| 2020's | 2 (4.88) | 2.80 |
| Authors | Studies |
|---|---|
| Artursson, P; Bergström, CA; Hoogstraate, J; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| Chen, L; He, Z; Li, H; Liu, J; Liu, X; Sui, X; Sun, J; Wang, Y; Zhang, W | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Bracher, M; Jackson, WP; Jacobs, P; Kalk, WJ; King, JB; Vinik, AI | 1 |
| Harrower, AD | 2 |
| Aranyi, Z; Ballagi-Pordány, G; Koltai, MZ; Köszeghy, A; Pogátsa, G | 1 |
| Boutagy, JS; Shenfield, GM; Webb, C | 1 |
| Harrower, AD; Wong, C | 1 |
| Almér, LO | 1 |
| Brasseur, R; Deleers, M; Gelbcke, M; Malaisse, WJ | 1 |
| Arfors, KE; Bergqvist, D; Tangen, O | 1 |
| Chow, CC; Cockram, CS; Sorensen, JP; Tsang, LW | 1 |
| Akkan, AG; Malaisse, WJ; Sener, A | 1 |
| Balabolkin, MI; Maksumova, MA; Orekhov, AN; Slavina, ES; Sobenin, IA | 1 |
| Gross, AS; Rieutord, A; Shenfield, GM; Stupans, I | 1 |
| Selvaag, E | 1 |
| Abenhaim, L; Monette, J; van Staa, T | 1 |
| Luo, M; O'Brien, RC | 1 |
| Bataille, D; Blache, P; Gros, L; Salazar, G; Virsolvy, A | 1 |
| Courtois, P; Herbaut, C; Malaisse, WJ; Sener, A; Turc, A | 1 |
| Gomis, R; Jones, NP; Patwardhan, RN; Squatrito, S; Wolffenbuttel, BH | 1 |
| de Smet, PA; Fischer, HR | 1 |
| Ravi, J; Ravisankar, S; Suresh, B; Vasudevan, M | 1 |
| Aburuz, S; McElnay, J; Millership, J | 1 |
| Choudhury, H; Harisudhan, T; Mullangi, R; Srinivas, NR; Venkatesh, P | 1 |
| Jin, SH; Li, ZR; Shi, YQ; Yao, J | 1 |
| Ee, JW; Kwon, SW; Lee, J; Lee, WJ; Park, JH; Shaodong, J | 1 |
| Chan, JC; Chow, CC; Ko, GT; Kong, AP; Luk, AO; Ma, RC; Ng, VW; Ozaki, R; So, WY; Tong, PC; Yang, X; Yu, LW | 1 |
| Abdelmoneim, AS; Brocks, DR; Hasenbank, SE; Light, PE; Seubert, JM; Simpson, SH | 1 |
| Binz, TM; Neels, H; Schneider, S; Villani, N | 1 |
| Bai, Y; Li, Z; Liu, HW; Xin, YL; Zhang, YW; Zhou, HH | 1 |
| Andersson, C; Fosbøl, EL; Gislason, G; Køber, L; Mogensen, UM; Scheller, NM; Schramm, TK; Torp-Pedersen, C; Vaag, A | 1 |
| Beassoni, P; Biasutti, MA; Boetsch, C; Challier, C; Criado, S; García, NA | 1 |
| Chen, GM; Lu, J; Shao, H; Xu, YT; Zhan, Y; Zhang, HJ | 1 |
| Azoulay, L; Douros, A; Filion, KB; Suissa, S; Yin, H; Yu, OHY | 1 |
| Allegretti, P; Biasutti, A; Challier, C; Criado, S; García, NA; Laurella, S; Sabini, C; Sabini, L | 1 |
| Cordiner, RLM; Pearson, ER | 1 |
| Huang, HK; Yeh, JI | 1 |
| Chiriac, FL; Iancu, VI; Radu, GL; Scutariu, RE | 1 |
| Gayakvad, B; Kothari, C; Patel, C; Patel, R; Solanki, R; Wadhwana, P | 1 |
3 review(s) available for gliclazide and glipizide
| Article | Year |
|---|---|
[Timing of administration of sulfonyl urea derivatives].
Topics: Biological Availability; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Drug Administration Schedule; Gliclazide; Glipizide; Glyburide; Humans; Hypoglycemic Agents; Tolbutamide | 2000 |
Variations in tissue selectivity amongst insulin secretagogues: a systematic review.
Topics: Animals; ATP-Binding Cassette Transporters; Carbamates; Cardiovascular Diseases; Cricetinae; Cyclohexanes; Diabetes Mellitus, Type 2; Gliclazide; Glipizide; Glyburide; Humans; Hypoglycemic Agents; Ischemic Preconditioning, Myocardial; Isoindoles; Mice; Muscle, Smooth, Vascular; Myocytes, Cardiac; Nateglinide; Phenylalanine; Piperidines; Potassium Channels, Inwardly Rectifying; Rats; Receptors, Drug; Risk Factors; Sulfonylurea Compounds; Sulfonylurea Receptors; Tolbutamide | 2012 |
Reflections on the sulphonylurea story: A drug class at risk of extinction or a drug class worth reviving?
Topics: Diabetes Mellitus; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Dose-Response Relationship, Drug; Gliclazide; Glipizide; Glucagon-Like Peptide-1 Receptor; Glyburide; History, 20th Century; History, 21st Century; Humans; Hypoglycemic Agents; Insulin Secretion; Insulin-Secreting Cells; Metformin; Sodium-Glucose Transporter 2 Inhibitors; Sulfonylurea Compounds; Treatment Failure | 2019 |
6 trial(s) available for gliclazide and glipizide
| Article | Year |
|---|---|
An evaluation of the effects of some sulphonylureas on platelet function.
Topics: Blood Glucose; Clinical Trials as Topic; Diabetes Mellitus; Female; Gliclazide; Glipizide; Humans; Lipids; Male; Middle Aged; Platelet Aggregation; Sulfonylurea Compounds | 1977 |
Efficacy of gliclazide in comparison with other sulphonylureas in the treatment of NIDDM.
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diet, Diabetic; Gliclazide; Glipizide; Glyburide; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Tolbutamide | 1991 |
Comparison of secondary failure rate between three second generation sulphonylureas.
Topics: Blood Glucose; Diabetes Mellitus, Type 2; Diet, Diabetic; Follow-Up Studies; Gliclazide; Glipizide; Glyburide; Glycated Hemoglobin; Humans; Random Allocation | 1990 |
Comparison of diabetic control in type 2 (non-insulin dependent) diabetic patients treated with different sulphonylureas.
Topics: Aged; Chlorpropamide; Clinical Trials as Topic; Diabetes Mellitus, Type 2; Gliclazide; Glipizide; Glyburide; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Middle Aged; Random Allocation; Sulfonylurea Compounds | 1985 |
Comparison of insulin with or without continuation of oral hypoglycemic agents in the treatment of secondary failure in NIDDM patients.
Topics: Analysis of Variance; Biomarkers; Blood Glucose; Body Mass Index; C-Peptide; Cholesterol; Cholesterol, HDL; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Female; Fructosamine; Gliclazide; Glipizide; Glyburide; Glycated Hemoglobin; Hexosamines; Humans; Hypoglycemic Agents; Insulin; Male; Metformin; Middle Aged; Treatment Failure; Triglycerides | 1995 |
Addition of low-dose rosiglitazone to sulphonylurea therapy improves glycaemic control in Type 2 diabetic patients.
Topics: Adult; Aged; Blood Glucose; C-Peptide; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Diabetes Mellitus, Type 2; Double-Blind Method; Drug Therapy, Combination; Europe; Female; Fructosamine; Gliclazide; Glipizide; Glyburide; Humans; Hypoglycemic Agents; Insulin; Male; Middle Aged; Rosiglitazone; Safety; Thiazoles; Thiazolidinediones; Triglycerides | 2000 |
32 other study(ies) available for gliclazide and glipizide
| Article | Year |
|---|---|
Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2).
Topics: Administration, Oral; Animals; Antineoplastic Agents; Antipsychotic Agents; Antiviral Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Cell Line; Computer Simulation; Cytochrome P-450 Enzyme System; Drug-Related Side Effects and Adverse Reactions; Estradiol; Humans; Insecta; Liver; Models, Molecular; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Pharmaceutical Preparations; Pharmacology; Structure-Activity Relationship | 2008 |
Prediction of volume of distribution values in human using immobilized artificial membrane partitioning coefficients, the fraction of compound ionized and plasma protein binding data.
Topics: Blood Proteins; Chemistry, Physical; Computer Simulation; Humans; Membranes, Artificial; Models, Biological; Pharmaceutical Preparations; Protein Binding; Tissue Distribution | 2009 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Divergent cardiac effects of the first and second generation hypoglycemic sulfonylurea compounds.
Topics: Animals; Arrhythmias, Cardiac; Blood Glucose; Carbutamide; Dose-Response Relationship, Drug; Electrocardiography; Gliclazide; Glipizide; Glyburide; Hypoglycemic Agents; Male; Myocardial Infarction; Potassium; Rats; Rats, Inbred Strains; Reference Values; Structure-Activity Relationship; Tolbutamide | 1990 |
A screening test for detecting sulfonylureas in plasma.
Topics: Aged; Aged, 80 and over; Chlorpropamide; Chromatography, High Pressure Liquid; Female; Gliclazide; Glipizide; Glyburide; Humans; Hypoglycemia; Male; Middle Aged; Sulfonylurea Compounds; Tolbutamide | 1990 |
Vascular fibrinolytic activity in long term treatment with second generation sulfonylurea compounds.
Topics: alpha-Macroglobulins; Blood Vessels; Chlorpropamide; Diabetes Mellitus; Endothelium; Fibrinolysis; Gliclazide; Glipizide; Humans; Plasminogen Activators; Plasminogen Inactivators; Sulfonylurea Compounds | 1980 |
Homologous and hybrid calcium complexes of A23187 and hypoglycemic sulfonylureas: nuclear magnetic resonance and conformational analysis.
Topics: Anti-Bacterial Agents; Calcimycin; Calcium; Chemical Phenomena; Chemistry; Gliclazide; Glipizide; Magnetic Resonance Spectroscopy; Molecular Conformation; Sulfonylurea Compounds; Tolbutamide | 1982 |
Effects of gliclazide--a new antidiabetic agent--on blood platelet function in vitro and in vivo.
Topics: Adenosine Diphosphate; Animals; Collagen; Female; Gliclazide; Glipizide; Hemostasis; Humans; In Vitro Techniques; Lasers; Male; Microcirculation; Platelet Aggregation; Rabbits; Sulfonylurea Compounds; Tolbutamide | 1980 |
Standardized procedure for the assay and identification of hypoglycemic sulfonylureas in human plasma.
Topics: Chromatography, High Pressure Liquid; Diabetes Mellitus, Type 2; Drug Monitoring; Forensic Medicine; Gliclazide; Glipizide; Glyburide; Humans; Hypoglycemia; Hypoglycemic Agents; Reproducibility of Results; Sensitivity and Specificity; Sulfonylurea Compounds | 1995 |
Sulfonylureas induce cholesterol accumulation in cultured human intimal cells and macrophages.
Topics: Adult; Animals; Cells, Cultured; Cholesterol; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Gliclazide; Glipizide; Glyburide; Humans; Macrophages, Peritoneal; Male; Mice; Mice, Inbred BALB C; Middle Aged; Muscle, Smooth, Vascular; Sulfonylurea Compounds; Tunica Intima | 1994 |
Gliclazide hydroxylation by rat liver microsomes.
Topics: Animals; Chromatography, High Pressure Liquid; Cytochrome P-450 CYP2D6; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Enzyme Inhibitors; Gliclazide; Glipizide; Glyburide; Hydroxylation; Hypoglycemic Agents; Kinetics; Male; Microsomes, Liver; Mixed Function Oxygenases; Rats; Rats, Sprague-Dawley; Tolbutamide | 1995 |
Photohemolytic potency of oral antidiabetic drugs in vitro: effects of antioxidants and a nitrogen atmosphere.
Topics: Antioxidants; Ascorbic Acid; Carbutamide; Chlorpropamide; Dose-Response Relationship, Drug; Gliclazide; Glipizide; Glyburide; Hemolysis; Humans; Hypoglycemic Agents; Nitrogen; Radiation-Sensitizing Agents; Reactive Oxygen Species; Sulfonamides; Sulfonylurea Compounds; Superoxide Dismutase; Tolazamide; Tolbutamide; Ultraviolet Rays; Vitamin E | 1996 |
Rates of hypoglycemia in users of sulfonylureas.
Topics: Adult; Aged; Chlorpropamide; Female; Gliclazide; Glipizide; Glyburide; Humans; Hypoglycemia; Hypoglycemic Agents; Incidence; Male; Middle Aged; Poisson Distribution; Risk; Risk Factors; Sulfonylurea Compounds; Surveys and Questionnaires; Time Factors; Tolbutamide | 1997 |
The effects of gliclazide and other sulfonylureas on low-density lipoprotein oxidation in vitro.
Topics: Administration, Oral; Adult; Antioxidants; Ascorbic Acid; Coronary Artery Disease; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Gliclazide; Glipizide; Glyburide; Humans; Hypoglycemic Agents; Lipoproteins, LDL; Male; Middle Aged; Oxidation-Reduction; Sulfonylurea Compounds; Tolbutamide | 1997 |
Characterization of low-affinity binding sites for glibenclamide on the Kir6.2 subunit of the beta-cell KATP channel.
Topics: Animals; ATP-Binding Cassette Transporters; Binding Sites; Blotting, Northern; Cell Line; Cell Membrane; COS Cells; Gliclazide; Glipizide; Glyburide; Islets of Langerhans; Kinetics; Organelles; Phentolamine; Potassium Channels; Potassium Channels, Inwardly Rectifying; Rats; Receptors, Drug; Recombinant Fusion Proteins; Sulfonylurea Compounds; Sulfonylurea Receptors; Tolbutamide; Transfection | 1999 |
Pharmacokinetics of gliquidone, glibenclamide, gliclazide and glipizide in middle-aged and aged subjects.
Topics: Aged; Female; Gliclazide; Glipizide; Glyburide; Half-Life; Humans; Hypoglycemic Agents; Male; Middle Aged; Sulfonylurea Compounds | 1999 |
ION-pair liquid chromatography technique for the estimation of metformin in its multicomponent dosage forms.
Topics: Chemistry, Pharmaceutical; Chromatography, High Pressure Liquid; Gliclazide; Glipizide; Hypoglycemic Agents; Metformin; Quality Control; Reference Standards; Reproducibility of Results | 2001 |
The development and validation of liquid chromatography method for the simultaneous determination of metformin and glipizide, gliclazide, glibenclamide or glimperide in plasma.
Topics: Chromatography, High Pressure Liquid; Gliclazide; Glipizide; Glyburide; Humans; Hypoglycemic Agents; Metformin; Reference Standards; Sensitivity and Specificity | 2005 |
Simultaneous estimation of six anti-diabetic drugs--glibenclamide, gliclazide, glipizide, pioglitazone, repaglinide and rosiglitazone: development of a novel HPLC method for use in the analysis of pharmaceutical formulations and its application to human p
Topics: Carbamates; Chromatography, High Pressure Liquid; Gliclazide; Glipizide; Glyburide; Humans; Hypoglycemic Agents; Molecular Structure; Pioglitazone; Piperidines; Reproducibility of Results; Rosiglitazone; Thiazolidinediones | 2006 |
Development of a RP-HPLC method for screening potentially counterfeit anti-diabetic drugs.
Topics: Carbamates; Chromatography, High Pressure Liquid; Gliclazide; Glipizide; Glyburide; Hypoglycemic Agents; Molecular Structure; Piperidines; Reproducibility of Results; Sulfonylurea Compounds | 2007 |
Comparison of ultraviolet detection, evaporative light scattering detection and charged aerosol detection methods for liquid-chromatographic determination of anti-diabetic drugs.
Topics: Aerosols; Chromatography, High Pressure Liquid; Chromatography, Reverse-Phase; Gliclazide; Glipizide; Glyburide; Hypoglycemic Agents; Light; Reproducibility of Results; Scattering, Radiation; Spectrophotometry, Ultraviolet; Sulfonylurea Compounds | 2010 |
Use of sulphonylurea and cancer in type 2 diabetes-The Hong Kong Diabetes Registry.
Topics: Aged; Asian People; Cohort Studies; Diabetes Mellitus, Type 2; Female; Gliclazide; Glipizide; Glyburide; Hong Kong; Humans; Male; Middle Aged; Neoplasms; Proportional Hazards Models; Prospective Studies; Registries; Risk Factors; Sulfonylurea Compounds | 2010 |
Rapid extraction, identification and quantification of oral hypoglycaemic drugs in serum and hair using LC-MS/MS.
Topics: Acetonitriles; Chromatography, Liquid; Female; Forensic Toxicology; Gliclazide; Glipizide; Glyburide; Hair; Humans; Hypoglycemic Agents; Limit of Detection; Male; Mass Spectrometry; Metformin; Methanol; Middle Aged; Molecular Structure; Solvents; Sulfonylurea Compounds | 2012 |
A lithium-rich composite metal oxide used as a SALDI-MS matrix for the determination of small biomolecules.
Topics: Chelating Agents; Citric Acid; Cyclodextrins; Edetic Acid; Gliclazide; Glipizide; Lipids; Lithium; Oligosaccharides; Oxides; Peptides; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 2014 |
Metformin in combination with various insulin secretagogues in type 2 diabetes and associated risk of cardiovascular morbidity and mortality--a retrospective nationwide study.
Topics: Aged; Carbamates; Cardiovascular Diseases; Denmark; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Female; Gliclazide; Glipizide; Glyburide; Humans; Hypoglycemic Agents; Male; Metformin; Middle Aged; Morbidity; Myocardial Infarction; Piperidines; Registries; Retrospective Studies; Risk Factors; Stroke; Sulfonylurea Compounds; Tolbutamide | 2015 |
Interaction between Human Serum Albumin and antidiabetic compounds and its influence on the O2((1)Δg)-mediated degradation of the protein.
Topics: Binding Sites; Gliclazide; Glipizide; Humans; Hypoglycemic Agents; Light; Molecular Docking Simulation; Oxidation-Reduction; Protein Binding; Protein Structure, Tertiary; Reactive Oxygen Species; Serum Albumin; Singlet Oxygen; Spectrometry, Fluorescence; Thermodynamics | 2015 |
Metabolic Interaction Potential between Clopidogrel and Sulfonylurea Antidiabetic Agents: Effects on Clopidogrel Bioactivation.
Topics: Carboxylic Ester Hydrolases; Clopidogrel; Cytochrome P-450 CYP1A2; Cytochrome P-450 CYP2B6; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP2C9 Inhibitors; Dose-Response Relationship, Drug; Drug Antagonism; Gliclazide; Glipizide; Humans; Hypoglycemic Agents; Intestines; Liver; Microsomes; Sulfonylurea Compounds; Ticlopidine | 2016 |
Pharmacologic Differences of Sulfonylureas and the Risk of Adverse Cardiovascular and Hypoglycemic Events.
Topics: Aged; Aged, 80 and over; Body Mass Index; Cardiovascular Diseases; Cohort Studies; Diabetes Mellitus, Type 2; Female; Follow-Up Studies; Gliclazide; Glipizide; Glycated Hemoglobin; Humans; Hypoglycemia; Hypoglycemic Agents; Incidence; Male; Middle Aged; Myocardial Infarction; Pancreas; Proportional Hazards Models; Risk Factors; Stroke; Sulfonylurea Compounds; Tolbutamide; United Kingdom | 2017 |
Reactive Oxygen Species-mediated Degradation of Antidiabetic Compounds: Cytotoxic Implications of Their Photodegradation Products.
Topics: Animals; Biotransformation; Cell Survival; Chlorocebus aethiops; Diabetes Mellitus, Type 2; Gliclazide; Glipizide; Humans; Hypoglycemic Agents; Kinetics; Light; Oxidation-Reduction; Photolysis; Photosensitizing Agents; Riboflavin; Singlet Oxygen; Solutions; Spectrometry, Fluorescence; Superoxides; Vero Cells | 2018 |
Comparison of mortality and cardiovascular event risk associated with various insulin secretagogues: A nationwide real-world analysis.
Topics: Aged; Carbamates; Cardiovascular Diseases; Cohort Studies; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Follow-Up Studies; Gliclazide; Glipizide; Glyburide; Humans; Hypoglycemic Agents; Insulin; Insulin Secretion; Male; Middle Aged; Mortality; Piperidines; Secretagogues; Sulfonylurea Compounds; Taiwan | 2019 |
Sensitive detection of antidiabetic compounds and one degradation product in wastewater samples by a new SPE-LC-MS/MS method.
Topics: Chromatography, Liquid; Environmental Monitoring; Gliclazide; Glipizide; Glyburide; Hypoglycemic Agents; Metformin; Reproducibility of Results; Solid Phase Extraction; Sulfonylurea Compounds; Tandem Mass Spectrometry; Wastewater; Water Pollutants, Chemical | 2021 |
Analytical Method Capable of Quantifying Eight Nitrosamine Impurities from Five Different Commercially Available Metformin Formulations with Glipizide, Glibenclamide, Gliclazide, Evogliptin, and Glimepiride by Ultra High Performance Liquid Chromatography
Topics: Chromatography, High Pressure Liquid; Chromatography, Liquid; Diabetes Mellitus, Type 2; Gliclazide; Glipizide; Glyburide; Humans; Metformin; Nitrosamines; Pharmaceutical Preparations; Tandem Mass Spectrometry | 2023 |